Paid Clinical Trials in Rogers, AR
As of July 2026, 51 paid clinical trials are recruiting in Rogers, Arkansas. Compensation typically covers time, travel, and study visits, with stipends ranging from modest amounts for short outpatient studies to several thousand dollars for long or inpatient protocols.
Rogers offers studies at sites including Highlands Oncology Group - Rogers for conditions such as Schizophrenia, Major Depressive Disorder, Melanoma, Non-Small Cell Lung Cancer. Both patients with specific conditions and healthy volunteers can qualify. Most trials offer free study-related medical care alongside compensation.
Recruiting trial data synced daily from ClinicalTrials.gov. Last sync: .
Trials by specialty in Rogers
Trials by drug in Rogers
Filter results
Newly added in Rogers
Posted to ClinicalTrials.gov within the last 60 days — these studies are just starting to recruit.
Efficacy of PP-01 in Mitigating Cannabis Withdrawal Symptoms in Adults With Cannabis Use Disorder
48 clinical trials
↓ Download CSVSymbiotic-GU-06: A Study to Learn About PF-08634404 Alone or In Combination With Enfortumab Vedotin in Urothelial Cancer
Symbiotic-Lung-01 : A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Chemotherapy in Adult Participants With Locally Advanced or Metastatic Non-Small Cell Lung Cancer
Symbiotic-GU-08: A Study to Learn About the Medicine Called PF-08634404 Dosed Alone and in Combination With Other Anticancer Therapies in Adults With Locally Advanced or Metastatic Renal Cell Cancer
Symbiotic-GI-03: A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Chemotherapy in Adult Participants With Metastatic Colorectal Cancer
Symbiotic-Lung-20: A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Different Anticancer Agents in Advanced Cancers
A Study to Learn About the Study Medicine Called PF-08046054/SGN-PDL1V Versus Docetaxel in Adult Participants With Previously-Treated Programmed Cell Death Ligand 1 (PD-L1) Positive Non-Small-Cell Lung Cancer (NSCLC)
This Study Will Explore Whether a Combination of the Investigational Drug Mevrometostat (PF-06821497) and Enzalutamide Will Work Better Than Taking Enzalutamide Alone in Participants With mCSPC Who Are ARPI naïve.
Long-Term Safety Study of Deucravacitinib Versus Ustekinumab in Participants With Psoriasis (PRAGMATYK)
A Randomized Study of Azetukalner Versus Placebo in Depressive Episodes Associated With Bipolar I or II Disorder (Bipolar Depression)
A Study to Learn How PF-06821497 (Mevrometostat) Works in Men With Metastatic Castration-resistant Prostate Cancer.
A Study of Sigvotatug Vedotin in Advanced Solid Tumors
A Study to Assess the Long-term Safety of KarXT for the Treatment of Manic Episodes in Bipolar-I Disorder (BALSAM-3)
MILD® Percutaneous Image-Guided Lumbar Decompression: A Medicare Claims Study
A Trial of the Efficacy and Safety of SEP-363856 in Acutely Psychotic Participants With Schizophrenia
A Study to Evaluate the Efficacy and Safety of KarXT for the Treatment of Manic Episodes in Bipolar-I Disorder (BALSAM-2)
A Study to Learn About the Study Medicine Called PF-07799544 as Monotherapy or in Combination in People With Advanced Solid Tumors
A Study to Learn About the Study Medicine Called PF-07799933 in People With Advanced Solid Tumors With BRAF Alterations.
A Study to Assess the Efficacy, Safety and Tolerability of VLS-01 Buccal Film, Compared to Placebo in Patients With Treatment Resistant Depression (ELUMINA)
Study of ITI-1284 as Monotherapy Treatment in Patients With Generalized Anxiety Disorder
A Randomized Study of Azetukalner Versus Placebo in Major Depressive Disorder
Symbiotic-Lung-04: A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Chemotherapy in Adult Participants With Extensive-Stage Small Cell Lung Cancer
A Study of Brenipatide in Adults Who Quit Smoking Cigarettes and Want to Avoid Relapse
Study Evaluating the Efficacy and Safety of RAP-219 in Adult Participants With Bipolar I Disorder
Safety and Efficacy of Brilaroxazine (RP5063) in Schizophrenia
ADCE-T02, a Tissue Factor Targeted Antibody-Drug Conjugate, in Patients With Selected Advanced Solid Tumours
A Study of XB371 Administered in Participants With Locally Advanced or Metastatic Solid Tumors
BostonGene and Exigent Genomic INsight Study
Adding Biotherapy or Placebo to Standard Treatment for Advanced Kidney Cancer
Testing the Addition of an Antiangiogenic Drug (Bevacizumab) to Chemotherapy (Carboplatin and Paclitaxel) Combined With Immunotherapy (Pembrolizumab) for pMMR, TP53 Mutated Endometrial Cancer
Pembrolizumab vs. Observation in People With Triple-negative Breast Cancer Who Had a Pathologic Complete Response After Chemotherapy Plus Pembrolizumab
Induction Pembrolizumab and Chemotherapy Followed by Pembrolizumab Before Chemoradiation and Pembrolizumab Maintenance Compared to Standard Chemoradiation With Pembrolizumab Followed by Pembrolizumab Maintenance in High-Risk Cervical Cancer
Testing the Role of DNA Released From Tumor Cells Into the Blood in Guiding the Use of Immunotherapy After Surgical Removal of the Bladder, Kidney, Ureter, and Urethra for Urothelial Cancer Treatment, MODERN Study
Combining Immunotherapy and Radiation Therapy to Help Patients Avoid Bladder Removal After Treatment Shrinks Muscle Invasive Bladder Cancer, BRIGHT Trial
Chemotherapy Combined With Immunotherapy Versus Immunotherapy Alone for Older Adults With Stage IIIB-IV Lung Cancer, The ACHIEVE Trial
Comparing Rituximab and Mosunetuzumab Drug Treatments for People With Low Tumor Burden Follicular Lymphoma
Testing the Addition of the Immunotherapy Drug, Pembrolizumab, to Radiation Therapy Compared to the Usual Chemotherapy Treatment During Radiation Therapy for Bladder Cancer, PARRC Trial
Studying Chemotherapy With or Without Panitumumab for Unresectable, Locally Advanced, or Metastatic Pancreatic Cancer Without KRAS Mutations
Testing Olaparib for One or Two Years, With or Without Bevacizumab, to Treat Ovarian Cancer
Candida Therapeutic Vaccine in Head and Neck Cancer Patients to Reduce Recurrence
Shorter Chemo-Immunotherapy Without Anthracycline Drugs for Early-Stage Triple Negative Breast Cancer
Top Research Study Locations in Rogers
Researchers run research studies in Rogers, AR at 15 active sites. The clinics below currently host the largest number of recruiting studies — each name is followed by the conditions they focus on most.
| Site | Specializes in | Active trials |
|---|---|---|
| Highlands Oncology Group - Rogers | Anatomic Stage II Breast Cancer AJCC v8, Anatomic Stage IIIA Breast Cancer AJCC v8, Anatomic Stage IIIB Breast Cancer AJCC v8 | 14 |
| Woodland Research Northwest | Bipolar Depression, Bipolar Disorder, Bipolar I Disorder | 9 |
| Highlands Oncology Group | Melanoma, Advanced Colorectal Cancer (Part 1), Advanced Non-Small Cell Lung Cancer | 8 |
| Highlands Oncology Group, PA | Non-Small Cell Lung Cancer, Advanced or Metastatic Solid Tumors, Advanced/Metastatic Non-Small Cell Lung Cancer | 6 |
| Arkansas Children's Research Institute | Eosinophilic Colitis, Eosinophilic Esophagitis, Eosinophilic Gastritis | 1 |
| Exelixis Clinical | Solid Tumors | 1 |
| Highlands Oncology | Metastatic Castration-Resistant Prostate Cancer | 1 |
| Local Institution - 0153 | Schizophrenia | 1 |
| Northwest Arkansas Clinical Trials Center (NWACTC), PLLC | Plaque Psoriasis | 1 |
| Precision Surgical Center of NWA | Lumbar Spinal Stenosis | 1 |
| Reviva site | Schizophrenia | 1 |
| Vanda Investigational Site | Schizophrenia | 1 |
| WRN | Focal Epilepsy | 1 |
| Woodland Research Northwest Site | Schizophrenia | 1 |
| Woodland Research Northwest, LLC | Cannabis Withdrawal | 1 |
Active & Upcoming Studies in Rogers (2026)
Recruiting trials in Rogers grouped by therapeutic area, drawn from ClinicalTrials.gov. Each bucket shows the most recent example studies.
Cancer & tumors (28 active studies)
- Adding Biotherapy or Placebo to Standard Treatment for Advanced Kidney Cancer · Phase 3 · SWOG Cancer Research Network
- Studying Chemotherapy With or Without Panitumumab for Unresectable, Locally Advanced, or Metastatic Pancreatic Cancer Without KRAS Mutations · Phase 3 · SWOG Cancer Research Network
Mental health & behavior (12 active studies)
- Relapse Prevention Trial Evaluating KarXT Treatment in Schizophrenia · Phase 3 · Karuna Therapeutics, Inc., a Bristol Myers Squibb company
- A Study of Brenipatide in Adults Who Quit Smoking Cigarettes and Want to Avoid Relapse · Phase 2 · Eli Lilly and Company
Diabetes & metabolic (1 active study)
Neurology & pain (1 active study)
- Long-term Safety and Tolerability of BHV-7000 · Phase 2 · Biohaven Therapeutics Ltd.
Common conditions studied in Rogers
- Schizophrenia (4 active studies)
- Major Depressive Disorder (3 active studies)
- Melanoma (3 active studies)
- Non-Small Cell Lung Cancer (3 active studies)
- Anatomic Stage II Breast Cancer AJCC v8 (2 active studies)
- Anatomic Stage IIIA Breast Cancer AJCC v8 (2 active studies)
Leading research sponsors in Rogers
- Pfizer
- National Cancer Institute (NCI)
- SWOG Cancer Research Network
- Xenon Pharmaceuticals Inc.
- Bristol-Myers Squibb
Frequently asked questions
How many paid clinical trials are currently recruiting in Rogers?
There are approximately 51 recruiting clinical trials in Rogers, Arkansas listed on ClinicalTrials.gov. The number changes weekly as new studies open and others close enrollment.
Do clinical trials in Rogers pay participants?
Most recruiting trials in Rogers compensate participants for their time, travel, and study visits. Compensation varies by sponsor, study phase, and visit requirements — the exact amount is disclosed by the study team during the informed consent process.
Who can participate in a clinical trial in Rogers?
Eligibility depends on the specific study. Each trial defines its own inclusion criteria (age, diagnosis, medical history, prior treatments) and exclusion criteria. Both patients with specific conditions and healthy volunteers can qualify, depending on the study design.
What conditions are most commonly studied in Rogers?
The most common conditions under active study in Rogers include Schizophrenia (4), Major Depressive Disorder (3), Melanoma (3), Non-Small Cell Lung Cancer (3), among many others. Browse the list above to explore every recruiting trial.
Are there clinical trials for healthy volunteers in Rogers?
Yes. Healthy-volunteer studies — often early-phase pharmacology or vaccine trials — recruit in Rogers on an ongoing basis. Use the "Healthy volunteers only" filter above to view trials that accept participants without the study's target condition.
How do I enroll in a clinical trial in Rogers?
Click any study title above to see the full study record, including eligibility criteria, visit schedule, and the study team's contact information. Reach out to the central contact or recruiting site directly — they will guide you through screening and informed consent.
Where can I take part in paid clinical trials in Rogers?
Recruiting research sites in Rogers include Highlands Oncology Group - Rogers, Woodland Research Northwest, Highlands Oncology Group, among others. Each site lists its open studies and contact information on the study record above — call or email the site coordinator to ask about screening for a specific protocol.
What kinds of studies are recruiting in Rogers right now?
The largest active categories in Rogers are Cancer & tumors (28), Mental health & behavior (12), Diabetes & metabolic (1). Use the filters above to narrow by therapeutic area, phase, age, or healthy-volunteer eligibility.